RT Journal Article
SR Electronic
T1 Global patterns and drivers of influenza decline during the COVID-19 pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.07.15.22277497
DO 10.1101/2022.07.15.22277497
A1 Bonacina, Francesco
A1 Boëlle, Pierre-Yves
A1 Colizza, Vittoria
A1 Lopez, Olivier
A1 Thomas, Maud
A1 Poletto, Chiara
YR 2022
UL http://medrxiv.org/content/early/2022/07/17/2022.07.15.22277497.abstract
AB Influenza circulation declined during the COVID-19 pandemic. The timing and extent of decline and its association with interventions against COVID-19 were described for some regions. Here, we provide a global analysis of the influenza decline between March 2020 and September 2021 and investigate its potential drivers. We computed influenza change by country and trimester relative to the 2014-2019 period using the number of samples in the FluNet database. We used random forests to determine important predictors in a list of 20 covariates including demography, weather, pandemic preparedness, COVID-19 incidence, and COVID-19 pandemic response. With a regression tree we then classified observations according to these predictors. We found that influenza circulation decreased globally, with COVID-19 incidence and pandemic preparedness being the two most important predictors of this decrease. The regression tree showed interpretable groups of observations by country and trimester: Europe and North America clustered together in spring 2020, with limited influenza decline despite strong COVID-19 restrictions; in the period afterwards countries of temperate regions, with high pandemic preparedness, high COVID-19 incidence and stringent social restrictions grouped together having strong influenza decline. Conversely, countries in the tropics, with altogether low pandemic preparedness, low reported COVID-19 incidence and low strength of COVID-19 response showed low influenza decline overall. A final group singled out four “zero-Covid” countries, with the lowest residual influenza levels. The spatiotemporal decline of influenza during the COVID-19 pandemic was global, yet heterogeneous. The sociodemographic context and stage of the COVID-19 pandemic showed non-linear associations with this decline. Zero-Covid countries maintained the lowest levels of reduction with strict border controls and despite close-to-normal social activity. These results suggest that the resurgence of influenza could take equally diverse paths. It also emphasises the importance of influenza reseeding in driving countries’ seasonal influenza epidemics.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe acknowledge financial support from the Municipality of Paris (https://www.paris.fr/) through the programme Emergence(s) to FB and CP; EU H2020 grants MOOD (H2020-874850) to PYB, VC and CP; Institut des Sciences du Calcul et de la Donnee.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study used only openly available influenza records that were originally located at FluNet (http://www.who.int/influenza/gisrs_laboratory/flunet/en/), and reported COVID-19 incidence retrieved from Ourworldindata (https://ourworldindata.org/coronavirus)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesProprietary airline data are commercially available from the International Air Transport Association (https://www.iata.org/) database. Restrictions apply to the availability of these data, which were used under license, and so are not publicly available. All other data are openly available online at the references cited in the manuscript. https://docs.google.com/spreadsheets/d/1PirC3iJ_yrlw9CoNL0_dkmXEI7DVVoJp/edit?usp=sharing&ouid=112424629266716674645&rtpof=true&sd=true